Partial deletion of the nicotinic cholinergic receptor α4 or β2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits

Molecular Pharmacology

Volumn 73, Issue 6, 2008, Pages 1796-1807

  Gotti, Cecilia ^a   Moretti, Milena ^a   Meinerz, Natalie M ^b   Clementi, Francesco ^a   Gaimarri, Annalisa ^a   Collins, Allan C ^b   Marks, Michael J ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; EPIBATIDINE; NICOTINIC CHOLINERGIC RECEPTOR ALPHA4; NICOTINIC CHOLINERGIC RECEPTOR BETA2; NICOTINIC RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBUNIT; RUBIDIUM 86; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN CORTEX; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; GENOTYPE; HETEROZYGOTE; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOICHIOMETRY; SYNAPTOSOME; THALAMUS; TRANSPORT KINETICS; WESTERN BLOTTING; WILD TYPE;

ACETYLCHOLINE; ANIMALS; CEREBRAL CORTEX; GENE DELETION; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; RUBIDIUM RADIOISOTOPES; THALAMUS;

EID: 44249097518     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.045203     Document Type: Article

References (41)

1. Anand R, Conroy WG, Schoepfer R, Whiting P, and Lindstrom J (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quarternary structure. J Biol Chem 266:11192- 11198.
2. Badio B and Daly JW (1994) Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 45:563-569.
3. Briggs CA, Gubbins EJ, Marks MJ, Putman CB, Thimmapaya R, Meyer MD, and Surowy CS (2006) Untranslated region-dependent exclusive expression of high-sensitivity subforms of α4β2 and α3β2 nicotinic acetylcholine receptors. Mol Pharmacol 70:227-240.
4. Brown RW, Collins AC, Lindstrom JM, and Whiteaker P (2007) Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem 103:204-215.
5. Buisson B and Bertrand D (2001) Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 21:1819-1829.
6. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, Clementi F, Moretti M, Rossi FM, LeNovere N, et al. (2003) Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23:7820-7829.
7. Cooper E, Couturier S, and Ballivet M (1991). Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350:235-238.
8. Covernton POJ and Connolly JG (2000) Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors. J Neurosci Methods 96:63-70.
9. 125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther 282:445-451.
10. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
11. Gotti C, Moretti M, Clementi F, Riganti L, McIntosh JM, Collins AC, Marks MJ, and Whiteaker P (2005a) Expression of nigrostriatal α6-containing nicotine acetylcholine receptors is selectively reduced, but not eliminated, by β3 subunit gene deletion. Mol Pharmacol 67:2007-2015.
12. Gotti C, Moretti M, Zanardi A, Gaimarri A, Champtiaux N, Changeux JP, Whiteaker P, Marks MJ, Clementi F, and Zoli M (2005b) Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype α3β2(α5 or β3) enriched in retinocollicular afferents. Mol Pharmacol 68:1162-1171.
13. Gotti C, Zoli M, and Clementi F (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27:482-491.
14. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
15. Khiroug SS, Khiroug L, and Yakel JL (2004) Rat nicotinic acetylcholine receptor α2β2 channels: comparison of functional properties with α4β2 channels in Xenopus oocytes. Neuroscience 124:817-822.
16. Kim H, Flanagin BA, Qin C, Macdonald RL, and Stitzel JA (2003) The mouse Chrna4 A529T polymorphism alters the ration of high and low affinity α4β2 nAChRs. Neuropharmacology 45:345-354.
17. Lindstrom J (2000) The structure of nAChRs, in Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology (Clementi F, Fornasari D, and Gotti C eds) vol 144, pp 101-162, Springer-Verlag, Berlin, Germany.
18. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275. 14907713 First author name does not match (LOWRY).
19. + efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology 53:390-405.
20. 125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46:1141-1157.
21. Marks MJ, Smith KW, and Collins AC (1998) Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther 285:377-386.
22. 3H]epibatidine binding of mice differing in β2 genotype. Neuropharmacology 39:2532-2645.
23. Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux JP, and Collins AC (1999) Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the β2 subunit. J Pharmacol Exp Ther 289:1090-1103.
24. 3H]epibatidine. Mol Pharmacol 70:947-959.
25. Marubio LM, Arroyo-Jimenex MD, Cordero-Erausquin M, Lena C, LeNovere N, d'Exaerde AD, Huchet M, Damaj MI, and Changeux JP (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398:805-810.
26. Moretti M, Vailati S, Zoli M, Lippi G, Riganti L, Longhi R, Viegi A, Clementi F, Gotti C (2004) Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience. Mol Pharmacol 66:85-96.
27. Moroni M, Zwart R, Sher E, Cassels BK, and Bermudez I (2006) α4β2 Nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol Pharmacol 70:755-768.
28. Mukhin AG, Gundish D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, et al. (2000) 5-Iodo-A-85380, an α4β2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol 57:642-649.
29. Nelson ME, Kuryatov A, Choi CH, Zhou Y, and Lindstrom J (2003) Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol 63:332-341.
30. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, LeNovere N, Vincent P, Pich E, Bruret P, and Changeux JP (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374:65-67.
31. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK, Scheffer IE, Kola I, Waddington JL, Berkovic SF, et al. (2000) Phenotypic characterization of an alpha4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20:6431-6441.
32. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, and Grady SR (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65:1526-1535.
33. 2+ permeability of the (α4)3(β2)2 stoichiometry greatly exceeds that of (α4)2(β2)3 human acetylcholine receptors. Mol Pharmacol 71:769-776.
34. Vailati S, Hanke W, Bejan A, Barabino B, Longhi R, Balestra B, Moretti M, Clementi F, and Gotti C (1999) Functional α6-containing nicotinic receptors are present in chick retina. Mol Pharmacol 56:11-19.
35. Whiteaker P, Cooper JF, Salminen O, Marks MJ, McClure-Begley TM, Brown RWB, Collins AC, and Lindstrom JM (2006) Immunolabeling demonstrates the interdependence of mouse brain α4 and β2 nicotinic acetylcholine receptor subunit expression. J Comp Neurol 499:1016-1038.
36. Whiteaker P, Marks MJ, Grady SR, Lu Y, Picciotto MR, Changeux JP, and Collins AC (2000) Pharmacological and null mutation approaches reveal nicotinic receptor diversity. Eur J Pharmacol 393:123-135.
37. Whiting P and Lindstrom J (1988) Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci 8:3395-3404.
38. Zhou Y, Nelson ME, Kuryatov A, Choi C, Cooper J, and Lindstrom J (2003) Human α4β2 acetylcholine receptors formed from linked subunits. J Neurosci 23:9004-9015.
39. Zoli M, Lena C, Picciotto MR, and Changeux J-P (1998) Identification of four classes of nicotinic receptors using beta2 mutant mice. J Neurosci 18:4461-4472.
40. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, and Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789.
41. Zwart R and Vijverberg HP (1998) Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 54:1124-1131.